122 related articles for article (PubMed ID: 11707316)
1. Cardiovascular effects of ketanserin on normotensive rats in vivo and in vitro.
Orallo F; Rosa E; García-Ferreiro T; Campos-Toimil M; Cadavid MI; Loza MI
Gen Pharmacol; 2000 Aug; 35(2):95-105. PubMed ID: 11707316
[TBL] [Abstract][Full Text] [Related]
2. Study of the in vivo and in vitro cardiovascular effects of (+)-glaucine and N-carbethoxysecoglaucine in rats.
Orallo F; Fernández Alzueta A; Campos-Toimil M; Calleja JM
Br J Pharmacol; 1995 Apr; 114(7):1419-27. PubMed ID: 7606346
[TBL] [Abstract][Full Text] [Related]
3. Study of the in vivo and in vitro cardiovascular effects of four new analogues of ketanserin: implication of 5-HT2A and alpha1 adrenergic antagonism in their hypotensive effect.
Orallo F; Tristan H; Garcia-Ferreiro T; De Francisco S; Masaguer C; Raviña E; Calleja JM; Cadavid I; Loza MI
Biol Pharm Bull; 2000 May; 23(5):558-65. PubMed ID: 10823664
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent.
Persson B; Hedner T; Henning M
J Pharm Pharmacol; 1982 Jul; 34(7):442-5. PubMed ID: 6126541
[TBL] [Abstract][Full Text] [Related]
5. Peripheral and central cardiovascular effects of ketanserin in conscious normotensive rats.
Davy M; Midol-Monnet M; Heimburger M; Beslot F; Cohen Y
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):193-206. PubMed ID: 3128194
[TBL] [Abstract][Full Text] [Related]
6. Urethane reduces contraction to 5-hydroxytryptamine (5-HT) and enhances the action of the 5-HT antagonist ketanserin on the rat thoracic aortic ring.
Dringenberg HC; Vanderwolf CH; Hamilton JT
J Neural Transm Gen Sect; 1995; 101(1-3):183-93. PubMed ID: 8695048
[TBL] [Abstract][Full Text] [Related]
7. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
[TBL] [Abstract][Full Text] [Related]
8. [Role of 5-HT2 receptors in the positive chronotropic action of serotonin on the isolated atria in rats].
el Rawadi C; Haddad R; Davy M; Midol-Monnet M; Cohen Y
C R Seances Soc Biol Fil; 1993; 187(3):390-7. PubMed ID: 8019915
[TBL] [Abstract][Full Text] [Related]
9. The influence of propranolol on the hypotensive action of ketanserin in normotensive rats.
Malinowska B; Pietraszek M; Chabielska E; Buczko W
Acta Physiol Pol; 1989; 40(4):356-62. PubMed ID: 2485607
[TBL] [Abstract][Full Text] [Related]
10. Study of the in vivo and in vitro cardiovascular effects of a hydralazine-like vasodilator agent (HPS-10) in normotensive rats.
Orallo F
Br J Pharmacol; 1997 Aug; 121(8):1627-36. PubMed ID: 9283696
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
Bolt GR; Saxena PR
Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
[TBL] [Abstract][Full Text] [Related]
12. Hypotensive effects of eugenosedin-A with serotonin, alpha- and beta-adrenoceptor antagonistic activities in spontaneously hypertensive and normotensive rats.
Shen KP; Chiu CC; Chen SJ; Chen IJ; Wu BN
Pharmacology; 2004 Jun; 71(2):91-101. PubMed ID: 15118348
[TBL] [Abstract][Full Text] [Related]
13. Antagonism by ketanserin of 5-HT-induced vasoconstriction unmasks a 5-HT-induced vasodilation.
McLennan PL; Taylor DA
Eur J Pharmacol; 1984 Sep; 104(3-4):313-8. PubMed ID: 6499925
[TBL] [Abstract][Full Text] [Related]
14. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
15. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats.
Cummings SA; Groszmann RJ; Kaumann AJ
Br J Pharmacol; 1986 Nov; 89(3):501-13. PubMed ID: 3801785
[TBL] [Abstract][Full Text] [Related]
16. AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
Barrett RJ; Appell KC; Kilpatrick BF; Proakis AG; Nolan JC; Walsh DA
J Cardiovasc Pharmacol; 1991 Jan; 17(1):41-53. PubMed ID: 1708055
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro activity of selective 5-hydroxytryptamine2 receptor antagonists.
Conolan S; Quinn MJ; Taylor DA
Br J Pharmacol; 1986 Sep; 89(1):129-35. PubMed ID: 3801767
[TBL] [Abstract][Full Text] [Related]
18. Three distinct subtypes of serotonergic receptors mediate the triphasic blood pressure response to serotonin in rats.
Kalkman HO; Engel G; Hoyer D
J Hypertens Suppl; 1984 Dec; 2(3):S143-5. PubMed ID: 6599662
[TBL] [Abstract][Full Text] [Related]
19. Interaction between Ca2+, verapamil, and ketanserin in rat tail artery and aorta.
Okoro EO; Marwood JF; Stokes GS
J Cardiovasc Pharmacol; 1995 Apr; 25(4):603-10. PubMed ID: 7596129
[TBL] [Abstract][Full Text] [Related]
20. Influence of alpha 1-adrenoceptor antagonism of ketanserin on the nature of its 5-HT2 receptor antagonism.
Marwood JF
Clin Exp Pharmacol Physiol; 1994 Dec; 21(12):955-61. PubMed ID: 7736654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
